Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Duvalumab

Condition:   Oesophageal Cancer
Intervention:   Drug: Durvalumab
Sponsors:   Simon C Pacey, MD;   AstraZeneca
Not yet recruiting

https://ift.tt/2N30Kox